Gisela Paulsen

2022 - Oncocyte Corp

In 2022, Gisela Paulsen earned a total compensation of $1.3M as Former President and Chief Operating Officer at Oncocyte Corp.

Compensation breakdown

Option Awards$233,738
Salary$356,426
Stock Awards$509,250
Other$241,712
Total$1,341,125

Paulsen received $509.3K in stock awards, accounting for 38% of the total pay in 2022.

Paulsen also received $233.7K in option awards, $356.4K in salary and $241.7K in other compensation.

Rankings

In 2022, Gisela Paulsen's compensation ranked 2,423rd out of 5,501 executives tracked by ExecPay. In other words, Paulsen earned more than 56.0% of executives.

ClassificationRankingPercentile
All
2,423
out of 5,501
56th
Division
Manufacturing
1,325
out of 2,980
56th
Major group
Chemicals And Allied Products
595
out of 1,335
55th
Industry group
Drugs
549
out of 1,238
56th
Industry
In Vitro and In Vivo Diagnostic Substances
6
out of 25
76th
Source: SEC filing on May 19, 2023.

Paulsen's colleagues

We found five more compensation records of executives who worked with Gisela Paulsen at Oncocyte Corp in 2022.

2022

Ronald Andrews

Oncocyte Corp

Chief Executive Officer

2022

Douglas Ross

Oncocyte Corp

Chief Scientific Officer

2022

Anish John

Oncocyte Corp

Chief Financial Officer

2022

Joshua Riggs

Oncocyte Corp

Chief Executive Officer

2022

James Liu

Oncocyte Corp

Controller and Principal Accounting Officer

News

You may also like